
Keywords: APC; adenomatous polyposis coli; AR; androgen receptor; CAFs; cancer-associated fibroblasts; CTL; cytotoxic T cells; EMT; epithelial-mesenchymal transition; EPCs; endothelial progenitor cells; FSP1; fibroblast specific protein 1; HNSCC; head and neck sq